Lineage price target lowered to $80 from $94 at Truist

Truist lowered the firm’s price target on Lineage (LINE) to $80 from $94 and keeps a Buy rating on the shares as part of a broader research note on REITs. The firm is updating its model to reflect Q3 results, recent events, and adjusted revenue growth and expense assumptions, the analyst tells investors in a research note.